Yu Saito

18PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMetabolomic chemistryHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 01, 2026
Clinical impact of salvage hepatectomy for local recurrence of hepatocellular carcinoma after radiofrequency ablation or selective transarterial chemoembolization.

|Jan 05, 2026
Mechanism of Lenvatinib Resistance via Exosomal miRNA-132/Nrf2 Axis in Hepatocellular Carcinoma.

Chie Takasu, Chiharu Nakasu, Yu Saito

|Sep 27, 2025
Oligomeric Proanthocyanidins Reverse Lenvatinib Resistance in Hepatocellular Carcinoma Through ITGA3-Mediated Pathway.

Takayuki Noma, Yuan Li, Yuma Wada

|Aug 04, 2025
Paradoxical carbon dioxide embolism through an iatrogenic atrial septal defect after catheter ablation for atrial fibrillation during laparoscopic hepatectomy: two case reports and a brief review of the literature (with video).

Yu Saito, Yuji Morine, Shinichiro Yamada

|May 03, 2025
Vascular endothelial growth factor released from lenvatinib-resistant hepatocellular carcinoma promotes malignant behavior and drug resistance through tumor-associated macrophages.

Yukako Takehara, Yuhei Waki, Yuji Morine

|Nov 06, 2024
Lenvatinib-resistant hepatocellular carcinoma promotes malignant potential of tumor-associated macrophages via exosomal miR-301a-3p.

Yuhei Waki, Yuji Morine, Yu Saito

Pageof 3

Frequent Collaborators

8 joint publications

Yuji Morine

8 joint publications

Shinichiro Yamada

6 joint publications

Tetsuya Ikemoto

3 joint publications

Yuhei Waki